Vistagen Therapeutics, Inc.
Ticker: VTGN
| Insider | Title |
|---|---|
| Ann Michelle Cunningham | Director |
| Bong Y Koh | 10% or greater ownership |
| Capital Lp Commodore | 10% or greater ownership |
| Co-investment Holdings Ii, Llc Vhcp | 10% or greater ownership |
| Co-investment Holdings Iii, Llc Vhcp | 10% or greater ownership |
| Cynthia Lynn Anderson | CHIEF FINANCIAL OFFICER |
| H. Ralph Snodgrass | PRES./CHIEF SCIENTIFIC OFFICER |
| Healthcare Capital Partners Eg, L.p. Venrock | 10% or greater ownership |
| Healthcare Capital Partners Ii, L.p. Venrock | 10% or greater ownership |
| Healthcare Capital Partners Iii, L.p. Venrock | 10% or greater ownership |
| Jerrold Duane Dotson | VP, CFO |
| Jerry B Gin | Director |
| Joanne Curley | Director |
| Jon S Saxe | Director |
| Joshua S. Prince | Chief Operating Officer |
| Management Eg, Llc Vhcp | 10% or greater ownership |
| Management Ii, Llc Vhcp | 10% or greater ownership |
| Management Iii, Llc Vhcp | 10% or greater ownership |
| Margaret M Fitzpatrick | Director |
| Mark Alan Smith | CHIEF MEDICAL OFFICER |
| Mary L. Rotunno | Director |
| Nimish P Shah | 10% or greater ownership |
| Reid G. Adler | CHF CORP DEVEL OFF, GEN COUNS |
| Shawn Singh | CHIEF EXECUTIVE OFFICER, Director |